Evidence map›Paper›PMID 31499196›Full record

SynthesisPharmacological research2019

Sex differences in the response to opioids for pain relief: A systematic review and meta-analysis.

Claudia Pisanu, Flavia Franconi, Gian Luigi Gessa, Sergio Mameli, Giovanni Maria Pisanu, Ilaria Campesi, Lorenzo Leggio, Roberta Agabio

Abstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Pharmacological research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Antinociceptive Effect and Hyperalgesia of Fentanyl and Its Analogues.International journal of molecular sciences · 2026
    Article
  10. Article
  11. Article
  12. Observational
  13. Observational
  14. Article
  15. Review
  16. Observational
  17. Review
  18. Sex differences in the transition to chronic pain.The Journal of clinical investigation · 2025
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Claudia PisanuDepartment of Biomedical Sciences, Section of Neuroscience and Clinical Pharmacology, University of Cagliari, S.S. 554, km. 4.500, I-09042, Monserrato, CA, Italy. Electronic address: claudia.pisanu@unica.it.
Flavia FranconiLaboratory of Sex-gender Medicine, National Institute of Biostructures and Biosystems, 07100, Sassari, Italy. Electronic address: franconi.flavia@gmail.com.
Gian Luigi GessaDepartment of Biomedical Sciences, Section of Neuroscience and Clinical Pharmacology, University of Cagliari, S.S. 554, km. 4.500, I-09042, Monserrato, CA, Italy. Electronic address: lgessa@unica.it.
Sergio MameliPain Therapy Unit, Azienda Ospedaliera "Brotzu", via Jenner snc, Cagliari, I-09121, Italy. Electronic address: sergiomameli@gmail.com.
Giovanni Maria PisanuPain Therapy Unit, Azienda Ospedaliera "Brotzu", via Jenner snc, Cagliari, I-09121, Italy. Electronic address: giommaria@tiscali.it.
Ilaria CampesiDepartment of Biomedical Sciences, University of Sassari, Viale San Pietro 43, 07100, Sassari, Italy. Electronic address: ilacampesi79@yahoo.it.
Lorenzo LeggioSection on Clinical Psychoneuroendocrinology and Neuropsychopharmacology, National Institute on Alcohol Abuse and Alcoholism Division of Intramural Clinical and Basic Research and National Institute on Drug Abuse Intramural Research Program, National Institutes of Health, 10 Center Drive (10CRC/15330), Bethesda, MD, 20892-1108, United States; Medication Development Program, National Institute on Drug Abuse Intramural Research Program, National Institutes of Health, 251 Bayview Blvd, Baltimore, MD, 21224, United States; Center for Alcohol and Addiction Studies, Brown University, Providence, RI, United States. Electronic address: lorenzo.leggio@nih.gov.
Roberta AgabioDepartment of Biomedical Sciences, Section of Neuroscience and Clinical Pharmacology, University of Cagliari, S.S. 554, km. 4.500, I-09042, Monserrato, CA, Italy. Electronic address: agabio@unica.it.

Funding

Clinical Psychoneuroendocrinology and Neuropsychopharmacology (CPN)ZIAAA000218 · NIAAA · NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM · PI LEGGIO, LORENZO · 2013 to 2020
$22.8M
Intramural NIH HHS Z99 DA999999Intramural NIH HHS ZIA AA000218NIAAA NIH HHS ZIA AA000218
6 · The paper itself

Abstract

There are conflicting results about sex differences in the response to opioids for pain control and the role of potential influencing factors of these differences has not been investigated. We meta-analyzed differences and similarities between men and women in opioid response for pain control and investigated the potential influence of baseline pain intensity, age, body weight, and other factors in these findings. PubMed, Scopus, and Cochrane CENTRAL were searched through January 15, 2019, for clinical studies in which opioids were administered for pain control. We included clinical studies in which (a) opioids were used to treat acute or chronic pain, (b) the response to opioids was broken down for men and women, and (c) the response to opioids was reported as (i) difference between baseline and final Visual Analog Scale of Pain Intensity (VASPI) score 30 min after opioid administration (Delta-VASPI at 30'), or daily dose of opioids (ii) self-administered by patients (patient-controlled analgesia PCA), or (iii) administered by physicians. Risk of bias was evaluated using ROBINS-I and the overall quality of evidence for primary outcomes was evaluated using the GRADE system. Globally, we included 40 comparisons (6794 patients). Regarding acute pain, we found moderate quality of evidence that women and men do not differ in their response to opioids 30 min after their administration [Delta-VASPI at 30': mean difference, MD = 0.42 (-0.07; 0.91)]. We also found moderate quality of evidence that women self-administer lower daily amounts of opioids [daily PCA: standardized mean difference, SMD = -0.30 (-0.41; -0.18)]. Regarding chronic pain, we found low quality of evidence that women receive lower daily doses for non-cancer pain [MD = -36.42 (-57.86; -14.99)]. By contrast, we found very low quality of evidence that women and men do not differ in the daily dose of opioids for cancer pain [MD = -16.09 (-40.13; 7.94)]. Age, comorbid mental disorders, type of administration, type of opioids, type of patients, and body weight significantly modified these results. In conclusion, the results of the present meta-analysis suggest that men and women may differ in the response to opioids for pain relief, but these differences as well as similarities are significantly influenced by factors like age and comorbid mental disorders. However, the role of these factors is not usually evaluated in the prescription of opioids for pain control. There is an urgent need to conduct clinical trials on the use of opioid medications for pain, in which information about all possible influencing factors are provided and broken down for men and women.

Indexed as

Analgesics, OpioidCancer PainChronic PainHumansPain ManagementAnalgesics, OpioidAcute painBuprenorphine (PubChem CID: 644073)Chronic painFentanyl (PubChem CID: 3345)Gender differencesHydrocodone (PubChem CID: 5284569)Hydromorphone (PubChem CID: 5284570)Morphine (PubChem CID: 5288826)Nalbuphine (PubChem CID: 5311304)OpioidsPentazocine (PubChem CID: 441278)Sex differencesTramadol (PubChem CID: 33741)Women

Identifiers

PMID31499196
PMCPMC12522423

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.